Inspire Medical Systems, Inc.

Inspire Medical Systems, Inc. manufactures Inspire® therapy, an FDA-approved implantable neurostimulation system for treating obstructive sleep apnea (OSA). The company's flagship product is a mask-free solution comprising three integrated components: an implantable pulse generator (IPG), a wireless remote control, and a companion mobile application. The system is designed for adult patients with moderate-to-severe OSA who have failed or are intolerant of continuous positive airway pressure (CPAP) therapy. The implant delivers upper airway stimulation during sleep to maintain airway patency and restore normal breathing patterns. Inspire therapy has been in clinical use for over a decade and is covered by most major commercial insurance plans, Medicare, and Veterans Affairs. The company reports clinical outcomes including 79% reduction in sleep apnea events, 90% of bed partners reporting no or soft snoring, and 93% of patients recommending the therapy. Inspire therapy received FDA approval for pediatric patients with Down Syndrome, expanding its addressable market. The system utilizes a smartphone app for therapy tracking and physician data sharing. Inspire Medical Systems partners with professional organizations including the American Academy of Sleep Medicine Foundation and the Sleep Research Society Foundation, indicating recognition within the sleep medicine specialty. The company conducts patient education through webinars and in-person events nationwide.